8I5Y: Human Nav1.7

Structure of human Nav1.7 in complex with vixotrigine. Determined by electron microscopy at 2.6 Å resolution. Released 14 Jun 2023.

Method
Electron microscopy
Resolution
2.6 Å
Organism
Homo sapiens
Chains
3
Atoms
13,617
Mol. weight
297.52 kDa
Ligands
NAG, P5S, Y01, 9Z9
Released
14 Jun 2023

Explore 8I5Y in 3D Show helices and sheets RCSB PDB PDBe

Secondary structure: helices and β-sheets

8I5Y contains 81 α-helices and 45 β-strands across 3 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.

Chain A: 74 helices, 18 β-strands

ElementResiduesLengthSheet
β-strand1411
α-helix17-3317
β-strand5812
α-helix59-602
α-helix61-633
α-helix68-703
β-strand75-7621
α-helix80-834
β-strand87-9151
β-strand9612
β-strand97-10151
α-helix1041
β-strand10513
β-strand10913
α-helix114-12310
α-helix126-14217
α-helix152-17423
α-helix187-20317
α-helix210-2178
α-helix218-2236
α-helix224-2274
α-helix231-24313
α-helix246-26722
α-helix270-2723
β-strand273-27754
α-helix286-2905
α-helix296-2994
β-strand30314
α-helix312-3143
α-helix322-3254
β-strand328-33254
α-helix335-3362
α-helix347-35913
α-helix363-37412
α-helix376-3783
α-helix379-3857
α-helix386-3938
α-helix394-41724
α-helix729-74012
α-helix743-76119
α-helix770-79728
α-helix800-8034
α-helix807-82418
α-helix834-84714
α-helix850-86213
α-helix867-89428
α-helix896-8983
α-helix913-92513
α-helix929-93911
α-helix941-96828
α-helix969-9735
α-helix987-101327
α-helix1176-119015
α-helix1192-120716
α-helix1220-124829
α-helix1250-12545
α-helix1257-127822
α-helix1284-12907
α-helix1291-130010
α-helix1305-134339
β-strand1349-135245
β-strand1357-135825
α-helix1359-13602
β-strand136616
α-helix1367-137610
β-strand1380-138345
α-helix1392-140312
α-helix1408-14169
β-strand142316
α-helix1431-14333
α-helix1434-14418
α-helix1442-14476
α-helix1448-146619
α-helix1476-148914
α-helix1491-14933
α-helix1495-15006
α-helix1503-151210
α-helix1515-153420
α-helix1541-156929
α-helix1570-15756
α-helix1577-160226
α-helix1606-16138
α-helix1614-16174
α-helix1618-16214
α-helix1623-16264
α-helix1629-166537
α-helix1684-169512
α-helix1700-17045
α-helix1705-17084
β-strand172017
β-strand172717
α-helix1733-176634
Chain B: 5 helices, 13 β-strands
ElementResiduesLengthSheet
α-helix24-274
β-strand29-3138
β-strand36-3839
β-strand41110
β-strand50-611211
β-strand68-74711
β-strand77-80411
α-helix84-863
β-strand90-9239
β-strand103110
β-strand106-10839
α-helix113-1153
β-strand117-1291311
β-strand132-135411
β-strand138-144711
β-strand145-14738
α-helix150-1534
α-helix154-19138
Chain C: 2 helices, 14 β-strands
ElementResiduesLengthSheet
β-strand31-33312
β-strand37-41513
β-strand46-48314
β-strand51-53312
β-strand64-70713
α-helix761
β-strand77-83713
β-strand87-89313
β-strand99-101314
β-strand104112
β-strand109112
β-strand112-114314
α-helix119-1213
β-strand123-130813
β-strand138-139213
β-strand142-147613

Molecules and chains

MoleculeChainsTypeLengthOrganismUniProt
Sodium channel protein type 9 subunit alphaAprotein2028Homo sapiensQ15858 (AlphaFold model)
Sodium channel subunit beta-1Bprotein218Homo sapiensQ07699 (AlphaFold model)
Sodium channel subunit beta-2Cprotein215Homo sapiensO60939 (AlphaFold model)
Sequence of entity 1 (A), FASTA
>8I5Y_1 Sodium channel protein type 9 subunit alpha (chains A)
WSHPQFEKGGGARGGSGGGSWSHPQFEKGFDYKDDDDKGTMAMLPPPGPQSFVHFTKQSL
ALIEQRIAERKSKEPKEEKKDDDEEAPKPSSDLEAGKQLPFIYGDIPPGMVSEPLEDLDP
YYADKKTFIVLNKGKTIFRFNATPALYMLSPFSPLRRISIKILVHSLFSMLIMCTILTNC
IFMTMNNPPDWTKNVEYTFTGIYTFESLVKILARGFCVGEFTFLRDPWNWLDFVVIVFAY
LTEFVNLGNVSALRTFRVLRALKTISVIPGLKTIVGALIQSVKKLSDVMILTVFCLSVFA
LIGLQLFMGNLKHKCFRNSLENNETLESIMNTLESEEDFRKYFYYLEGSKDALLCGFSTD
SGQCPEGYTCVKIGRNPDYGYTSFDTFSWAFLALFRLMTQDYWENLYQQTLRAAGKTYMI
FFVVVIFLGSFYLINLILAVVAMAYEEQNQANIEEAKQKELEFQQMLDRLKKEQEEAEAI
AAAAAEYTSIRRSRIMGLSESSSETSKLSSKSAKERRNRRKKKNQKKLSSGEEKGDAEKL
SKSESEDSIRRKSFHLGVEGHRRAHEKRLSTPNQSPLSIRGSLFSARRSSRTSLFSFKGR
GRDIGSETEFADDEHSIFGDNESRRGSLFVPHRPQERRSSNISQASRSPPMLPVNGKMHS
AVDCNGVVSLVDGRSALMLPNGQLLPEVIIDKATSDDSGTTNQIHKKRRCSSYLLSEDML
NDPNLRQRAMSRASILTNTVEELEESRQKCPPWWYRFAHKFLIWNCSPYWIKFKKCIYFI
VMDPFVDLAITICIVLNTLFMAMEHHPMTEEFKNVLAIGNLVFTGIFAAEMVLKLIAMDP
YEYFQVGWNIFDSLIVTLSLVELFLADVEGLSVLRSFRLLRVFKLAKSWPTLNMLIKIIG
NSVGALGNLTLVLAIIVFIFAVVGMQLFGKSYKECVCKINDDCTLPRWHMNDFFHSFLIV
FRVLCGEWIETMWDCMEVAGQAMCLIVYMMVMVIGNLVVLNLFLALLLSSFSSDNLTAIE
EDPDANNLQIAVTRIKKGINYVKQTLREFILKAFSKKPKISREIRQAEDLNTKKENYISN
HTLAEMSKGHNFLKEKDKISGFGSSVDKHLMEDSDGQSFIHNPSLTVTVPIAPGESDLEN
MNAEELSSDSDSEYSKVRLNRSSSSECSTVDNPLPGEGEEAEAEPMNSDEPEACFTDGCV
WRFSCCQVNIESGKGKIWWNIRKTCYKIVEHSWFESFIVLMILLSSGALAFEDIYIERKK
TIKIILEYADKIFTYIFILEMLLKWIAYGYKTYFTNAWCWLDFLIVDVSLVTLVANTLGY
SDLGPIKSLRTLRALRPLRALSRFEGMRVVVNALIGAIPSIMNVLLVCLIFWLIFSIMGV
NLFAGKFYECINTTDGSRFPASQVPNRSECFALMNVSQNVRWKNLKVNFDNVGLGYLSLL
QVATFKGWTIIMYAAVDSVNVDKQPKYEYSLYMYIYFVVFIIFGSFFTLNLFIGVIIDNF
NQQKKKLGGQDIFMTEEQKKYYNAMKKLGSKKPQKPIPRPGNKIQGCIFDLVTNQAFDIS
IMVLICLNMVTMMVEKEGQSQHMTEVLYWINVVFIILFTGECVLKLISLRHYYFTVGWNI
FDFVVVIISIVGMFLADLIETYFVSPTLFRVIRLARIGRILRLVKGAKGIRTLLFALMMS
LPALFNIGLLLFLVMFIYAIFGMSNFAYVKKEDGINDMFNFETFGNSMICLFQITTSAGW
DGLLAPILNSKPPDCDPKKVHPGSSVEGDCGNPSVGIFYFVSYIIISFLVVVNMYIAVIL
ENFSVATEESTEPLSEDDFEMFYEVWEKFDPDATQFIEFSKLSDFAAALDPPLLIAKPNK
VQLIAMDLPMVSGDRIHCLDILFAFTKRVLGESGEMDSLRSQMEERFMSANPSKVSYEPI
TTTLKRKQEDVSATVIQRAYRRYRLRQNVKNISSIYIKDGDRDDDLLNKKDMAFDNVNEN
SSPEKTDATSSTTSPPSYDSVTKPDKEKYEQDRTEKEDKGKDSKESKK
Sequence of entity 2 (B), FASTA
>8I5Y_2 Sodium channel subunit beta-1 (chains B)
MGRLLALVVGAALVSSACGGCVEVDSETEAVYGMTFKILCISCKRRSETNAETFTEWTFR
QKGTEEFVKILRYENEVLQLEEDERFEGRVVWNGSRGTKDLQDLSIFITNVTYNHSGDYE
CHVYRLLFFENYEHNTSVVKKIHIEVVDKANRDMASIVSEIMMYVLIVVLTIWLVAEMIY
CYKKIAAATETAAQENASEYLAITSESKENCTGVQVAE
Sequence of entity 3 (C), FASTA
>8I5Y_3 Sodium channel subunit beta-2 (chains C)
MHRDAWLPRPAFSLTGLSLFFSLVPPGRSMEVTVPATLNVLNGSDARLPCTFNSCYTVNH
KQFSLNWTYQECNNCSEEMFLQFRMKIINLKLERFQDRVEFSGNPSKYDVSVMLRNVQPE
DEGIYNCYIMNPPDRHRGHGKIHLQVLMEEPPERDSTVAVIVGASVGGFLAVVILVLMVV
KCVRRKKEQKLSTDDLKTEEEGKTDGEGNPDDGAK

Ligands and cofactors

IDNameFormulaCopies
NAG2-acetamido-2-deoxy-beta-D-glucopyranoseC8 H15 N O65
P5SO-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serineC42 H82 N O10 P1
Y01Cholesterol hemisuccinateC31 H50 O44
9Z9(3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-enC34 H56 O51
TB4VixotrigineC18 H19 F N2 O21
LPE1-O-octadecyl-sn-glycero-3-phosphocholineC26 H57 N O6 P14
1PW(2S,3R,4E)-2-(acetylamino)-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphateC20 H40 N O6 P1
PCW1,2-dioleoyl-sn-glycero-3-phosphocholineC44 H85 N O8 P5

Water and common crystallization additives (NA) are not listed.

Primary citation

Structural mapping of Na v 1.7 antagonists. Wu, Q., Huang, J., Fan, X. et al. Nat Commun (2023) 14:3224-3224. DOI 10.1038/s41467-023-38942-3 · PubMed

Other PDB entries of the same protein (UniProt Q15858 (AlphaFold model), which also has an AlphaFold model), best resolution first:

Browse structure collections

About this viewer

MolViewer shows 8I5Y directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.